
The Role of Treg Cells in the Cancer Immunological Response
Author(s) -
Zhi Zhang Yang,
Stephen M. Ansell
Publication year - 2009
Publication title -
american journal of immunology
Language(s) - English
Resource type - Journals
eISSN - 1558-3775
pISSN - 1553-619X
DOI - 10.3844/ajisp.2009.17.28
Subject(s) - treg cell , immunology , cancer , antibody response , biology , immune system , genetics , t cell , il 2 receptor
Problem statement: T cell-mediated immunosuppression has been
observed for decades without clarification as to which factor was responsible
for this observation. The identification of CD4+CD25+ regulatory T (Treg) cells
represents a milestone in the filed of immunology and provides an explanation
for T-cell-mediated immunosuppression. Although Treg cells were originally identified
for their ability to prevent organ-specific autoimmune disease in mice, emerging
evidence suggests that Treg cells play a pivotal role in tumor immunity and contribute
to tumor growth and progression, thereby having an important impact on the outcome
of cancer patients. Approach: This article reviewed the medical
literature to describe how Treg cells affect anti-tumor immunity. Results:
Treg cells suppressed anti-tumor immunity by inhibiting the effector functions
of tumor-specific T cells and NK cells. Importantly, tumor cells played an active
role in recruiting and generating Treg cells and creating a suppressive tumor
microenvironment. Strategies to deplete Treg cells or inhibit their function had
yielded promising results by enhancing anti-tumor immunity in experimental studies
as well as clinical practice. Conclusion: A better understanding
of the pathophysiology of Treg cells not only increased our knowledge in a variety
of aspects of immunology but also potentially benefited cancer patients